These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 25246229)

  • 1. The influence of the HPG axis on stress response and depressive-like behaviour in a transgenic mouse model of Huntington's disease.
    Du X; Pang TY; Mo C; Renoir T; Wright DJ; Hannan AJ
    Exp Neurol; 2015 Jan; 263():63-71. PubMed ID: 25246229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease.
    Du X; Leang L; Mustafa T; Renoir T; Pang TY; Hannan AJ
    Transl Psychiatry; 2012 Jul; 2(7):e133. PubMed ID: 22760557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice.
    Mo C; Renoir T; Hannan AJ
    Neurobiol Dis; 2014 Nov; 71():81-94. PubMed ID: 25088714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortisol and depression in pre-diagnosed and early stage Huntington's disease.
    Shirbin CA; Chua P; Churchyard A; Lowndes G; Hannan AJ; Pang TY; Chiu E; Stout JC
    Psychoneuroendocrinology; 2013 Nov; 38(11):2439-47. PubMed ID: 24074804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease.
    Björkqvist M; Petersén A; Bacos K; Isaacs J; Norlén P; Gil J; Popovic N; Sundler F; Bates GP; Tabrizi SJ; Brundin P; Mulder H
    Hum Mol Genet; 2006 May; 15(10):1713-21. PubMed ID: 16613897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-pituitary-adrenal axis functioning in Huntington's disease and its association with depressive symptoms and suicidality.
    Hubers AA; van der Mast RC; Pereira AM; Roos RA; Veen LJ; Cobbaert CM; van Duijn E; Giltay EJ
    J Neuroendocrinol; 2015 Mar; 27(3):234-44. PubMed ID: 25565388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High stress hormone levels accelerate the onset of memory deficits in male Huntington's disease mice.
    Mo C; Pang TY; Ransome MI; Hill RA; Renoir T; Hannan AJ
    Neurobiol Dis; 2014 Sep; 69():248-62. PubMed ID: 24825316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease.
    Pang TY; Du X; Zajac MS; Howard ML; Hannan AJ
    Hum Mol Genet; 2009 Feb; 18(4):753-66. PubMed ID: 19008301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexually dimorphic dopaminergic dysfunction in a transgenic mouse model of Huntington's disease.
    Renoir T; Argyropoulos A; Chevarin C; Lanfumey L; Hannan AJ
    Pharmacol Biochem Behav; 2014 Dec; 127():15-20. PubMed ID: 25316307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant-Like Effect of the Norepinephrine-Dopamine Reuptake Inhibitor Bupropion in a Mouse Model of Huntington's Disease with Dopaminergic Dysfunction.
    Renoir T; Argyropoulos A; Hannan AJ
    J Huntingtons Dis; 2012; 1(2):261-6. PubMed ID: 25063334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of Complexin II does not affect disease progression in a mouse model of Huntington's disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD.
    Glynn D; Reim K; Brose N; Morton AJ
    Brain Res Bull; 2007 Apr; 72(2-3):108-20. PubMed ID: 17352934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.
    Dufour BD; McBride JL
    Exp Neurol; 2016 Sep; 283(Pt A):308-17. PubMed ID: 27381424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.
    Renoir T; Zajac MS; Du X; Pang TY; Leang L; Chevarin C; Lanfumey L; Hannan AJ
    PLoS One; 2011; 6(7):e22133. PubMed ID: 21760962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deterioration of neuroregenerative plasticity in association with testicular atrophy and dysregulation of the hypothalamic-pituitary-gonadal (HPG) axis in Huntington's disease: A putative role of the huntingtin gene in steroidogenesis.
    Selvaraj K; Manickam N; Kumaran E; Thangadurai K; Elumalai G; Sekar A; Radhakrishnan RK; Kandasamy M
    J Steroid Biochem Mol Biol; 2020 Mar; 197():105526. PubMed ID: 31715317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of the Sexually Dimorphic Neuro-Inflammatory Response in a Transgenic Mouse Model of Huntington's Disease.
    Renoir T; Pang TY; Shikano Y; Li S; Hannan AJ
    J Huntingtons Dis; 2015; 4(4):297-303. PubMed ID: 26599196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased thirst and drinking in Huntington's disease and the R6/2 mouse.
    Wood NI; Goodman AO; van der Burg JM; Gazeau V; Brundin P; Björkqvist M; Petersén A; Tabrizi SJ; Barker RA; Morton AJ
    Brain Res Bull; 2008 May; 76(1-2):70-9. PubMed ID: 18395613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethological endophenotypes are altered by elevated stress hormone levels in both Huntington's disease and wildtype mice.
    Mo C; Renoir T; Hannan AJ
    Behav Brain Res; 2014 Nov; 274():118-27. PubMed ID: 25101541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice selected for high versus low stress reactivity: a new animal model for affective disorders.
    Touma C; Bunck M; Glasl L; Nussbaumer M; Palme R; Stein H; Wolferstätter M; Zeh R; Zimbelmann M; Holsboer F; Landgraf R
    Psychoneuroendocrinology; 2008 Jul; 33(6):839-62. PubMed ID: 18502051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease.
    Hult Lundh S; Nilsson N; Soylu R; Kirik D; Petersén Å
    Hum Mol Genet; 2013 Sep; 22(17):3485-97. PubMed ID: 23697793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease.
    Aziz NA; Pijl H; Frölich M; van der Graaf AW; Roelfsema F; Roos RA
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1223-8. PubMed ID: 19174491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.